Finland: Pihlajalinna intends to issue €20m in hybrid capital securities
Pihlajalinna, a leading provider of private healthcare and wellbeing services in Finland, is considering issuance of a minimum €20m (US$21.4m) in hybrid capital securities.
Net...
Malaysia: KPJ raises debt and sells Indonesia assets
Point Zone, a subsidiary of KPJ Healthcare, the Malaysian based regional healthcare provider, is reported to have raised RM555m (US$123m) from a sukuk offering launched...
Israel: Redhill Bio places US$6m convertible promissory note with one investor
Redhill Biopharma, a specialty biopharmaceutical company, has placed a US$6m convertible promissory note (convertible into ADS) and warrants with a single investor.
Advances under the...
New Zealand: Summerset raises NZ$150m from retail bond offering
Summerset Group Holdings, which develops, owns, and operates integrated retirement villages, has closed its fixed rate retail bond offer at a rate of 6.59%...
Early stage funding: Allorion Therapeutics, Logex, SiYi Intelligence, Vitraya Technologies
India: Vitraya Technologies, a technology platform that enables automated claims decision making for insurers and real-time payouts to providers, has raised US$4.1m in a...
Italy: Archimed acquires fast-growing consumer health player, WiQo
Global private equity healthcare specialist Archimed has acquired European consumer health player, WiQo. Archimed’s acquisition of the Muggia-based pioneer in aesthetic medicine will accelerate...
Singapore: Natixis CIB closes hybrid facility for R-Bridge Healthcare Fund
Natixis Corporate & Investment Banking, part of BPCE the second largest banking group in France. recently closed a US$120m hybrid facility for R-Bridge Healthcare...
Switzerland: GeNeuro signs credit agreement with EIB to help fund long-Covid trials
Geneva-based GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, has signed a credit agreement for up to €25m (US$26.4m) with...
Switzerland: Noema Pharma closes Series B at CHF103m
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, has closed an oversubscribed Series B financing round, raising CHF103m (US$112m) from...
Australia: Australian Unity looks to raise A$350m to fund acquisitions and strengthen balance sheet
Australian Unity’s A$3.8bn (US$2.5bn) Healthcare Property Trust (AUHPT)—the largest unlisted healthcare REIT in Australia—has re-opened to seek to raise approximately A$350m to provide funding...
©2023 All rights reserved LaingBuisson 
